XML 54 R13.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2020
Earnings Per Share [Abstract] |
Earnings Per Share |
4. | Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2020 and 2019 (in thousands, except per share amounts):
|  | Three Months Ended March 31, |
|  | 2020 |  |  | 2019 |
Numerator: |  |  |  |  |  |  |  |
Net income attributable to Acadia Healthcare Company, Inc. |  | $ | 33,463 |  |  | $ | 29,471 |
Denominator: |  |  |  |  |  |  |  |
Weighted average shares outstanding for basic earnings per share |  |  | 87,765 |  |  |  | 87,505 |
Effect of dilutive instruments |  |  | 206 |  |  |  | 189 |
Shares used in computing diluted earnings per common share |  |  | 87,971 |  |  |  | 87,694 |
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |
Basic |  | $ | 0.38 |  |  | $ | 0.34 |
Diluted |  | $ | 0.38 |  |  | $ | 0.34 |
Approximately 2.9 million and 2.6 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for the three months ended March 31, 2020 and 2019, respectively, because their effect would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration